BridgeMD
Tests treatment safety and results for Implant Dentistry
Official title Efficacy of Xenograft Alone or Mixed With Arginyl-Glycyl-Aspartic Acid (RGD) in Horizontal Ridge Augmentation With Split-crest Technique for Implant Placement
ClinicalTrials.gov ID: NCT06585852
What this study is testing
What is RGD?
RGD is an investigational medicine, being studied as a potential treatment for implant dentistry.
Also referred to as Arginylglycylaspartic acid.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The aim of the present study is to evaluate the efficacy of xenograft alone or xenograft mixed with Arginylglycylaspartic acid (RGD) , in horizontal ridge augmentation with split-crest technique, for implant placement.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 30. Healthy volunteers may be eligible.
You may be able to join if
- Adults (age 18-30) exhibiting initial insufficiently bone width.
- Patients with good oral hygiene.
- Patients must be free from systemic diseases that may influence the outcome of the therapy.
- Patients with bony horizontal defects alone, Class III \& IV.
You likely can't join if
- Heavy smokers.
- Patient treated by immunosuppressive chemotherapy or radio therapy,
- Allergy to any material or medication used in the study.
- Pregnant females.
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Nasr City, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 30 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Nasr City, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.